Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

1(14%)

Results Posted

20%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

N/ANon-phased studies

7(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Terminated(1)

Detailed Status

Completed5

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

N/A

Trials by Phase

N/A7 (100.0%)

Trials by Status

recruiting114%

terminated114%

completed571%

Recent Activity

1 active trials

Showing 5 of 7

completednot_applicable

Air Pollution and Physical Activity Study

NCT06386055

completednot_applicable

Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program

NCT03417531

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT06386055Not Applicable

Air Pollution and Physical Activity Study

Completed

NCT03417531Not Applicable

Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program

Completed

NCT03371225Not Applicable

Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System

Completed

NCT04426786Not Applicable

Exercise & Brain Energetics in PD

Recruiting

NCT05596058Not Applicable

Non-pharmacological Treatments in Migraine.

Terminated

NCT02189018Not Applicable

Activity To Improve Outcomes in Peripheral Arterial Disease

Completed

NCT01835652Not Applicable

The Effects of Exercise in Parkinson's Disease

Completed

All 7 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 7